Heterocyclic aspartyl protease inhibitors

Details for Australian Patent Application No. 2008219071 (hide)

Owner SCHERING CORPORATION PHARMACOPEIA, LLC

Inventors Qu, Chuanxing; Saionz, Kurt W.; Guo, Tao; Morris, Michelle L.; Shao, Yuefei; Pan, Jianping; Stamford, Andrew; Lai, Gaifa; Le, Thuy X. H.; Wang, Lingyan; McKittrick, Brian; Ye, Yuanzan C.; Qian, Gang; Liu, Xiaoxiang; Wu, Yusheng; Caldwell, John; Duo, Jingqi; Misiaszek, Jeffrey A.; Zhu, Zhaoning; Huang, Ying; Li, Guoqing; Gu, Huizhong; Mazzola Jr., Robert D.; Sun, Zhong-Yue; Cumming, Jared N.; Tadesse, Dawit; Voigt, Johannes H.; Iserloh, Ulrich; Strickland, Corey; Hunter, Rachael C.; Greenlee, William J.; Ba

Agent Griffith Hack

Pub. Number AU-A-2008219071

PCT Pub. Number WO2008/103351

Priority 11/710,582 23.02.07 US

Filing date 20 February 2008

Wipo publication date 28 August 2008

International Classifications

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 239/22 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 495/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

17 September 2009 Assignment before Grant

  PHARMACOPEIA, INC.; SCHERING CORPORATION The application has been assigned to SCHERING CORPORATION; PHARMACOPEIA, LLC

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/103351 Priority application(s): WO2008/103351

25 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Nov 2010

4 October 2012 Alteration of Name

  The name of the applicant has been altered to PHARMACOPEIA, LLC; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219083-Energy focusing system for active denial apparatus

2008219065-Hemostatic compositions and therapeutic regimens